161 related articles for article (PubMed ID: 26103538)
41. Sex differences in serum leptin and its relation to markers of cardiometabolic risk in middle-aged adults: evidence from a population-based study.
de Castro MA; Baltar VT; Marchioni DM; Fisberg RM
Nutrition; 2015 Mar; 31(3):491-7. PubMed ID: 25701340
[TBL] [Abstract][Full Text] [Related]
42. C-reactive protein and incident diabetes in patients with arterial disease.
Verhagen SN; Wassink AM; van der Graaf Y; Visseren FL;
Eur J Clin Invest; 2013 Oct; 43(10):1052-9. PubMed ID: 23919838
[TBL] [Abstract][Full Text] [Related]
43. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype.
Phillips CM; Tierney AC; Perez-Martinez P; Defoort C; Blaak EE; Gjelstad IM; Lopez-Miranda J; Kiec-Klimczak M; Malczewska-Malec M; Drevon CA; Hall W; Lovegrove JA; Karlstrom B; Risérus U; Roche HM
Obesity (Silver Spring); 2013 Jan; 21(1):E154-61. PubMed ID: 23505198
[TBL] [Abstract][Full Text] [Related]
44. Obesity and cardiovascular disease: role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system.
Lastra G; Sowers JR
Horm Mol Biol Clin Investig; 2013 Sep; 15(2):49-57. PubMed ID: 25436732
[TBL] [Abstract][Full Text] [Related]
45. Epigenetic processing in cardiometabolic disease.
Costantino S; Mohammed SA; Ambrosini S; Paneni F
Atherosclerosis; 2019 Feb; 281():150-158. PubMed ID: 30290963
[TBL] [Abstract][Full Text] [Related]
46. Inflammatory mechanisms linking obesity and metabolic disease.
Saltiel AR; Olefsky JM
J Clin Invest; 2017 Jan; 127(1):1-4. PubMed ID: 28045402
[TBL] [Abstract][Full Text] [Related]
47. MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes.
Coope A; Torsoni AS; Velloso LA
Eur J Endocrinol; 2016 May; 174(5):R175-87. PubMed ID: 26646937
[TBL] [Abstract][Full Text] [Related]
48. Chronic activation of the innate immune system may underlie the metabolic syndrome.
Duncan BB; Schmidt MI
Sao Paulo Med J; 2001 May; 119(3):122-7. PubMed ID: 11391456
[TBL] [Abstract][Full Text] [Related]
49. Diabesity: an inflammatory metabolic condition.
Schmidt MI; Duncan BB
Clin Chem Lab Med; 2003 Sep; 41(9):1120-30. PubMed ID: 14598860
[TBL] [Abstract][Full Text] [Related]
50. Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology.
Lin X; Onda DA; Yang CH; Lewis JR; Levinger I; Loh K
Mol Metab; 2020 Oct; 40():101040. PubMed ID: 32544571
[TBL] [Abstract][Full Text] [Related]
51. Interplay between Oxidative Stress and Inflammation in Cardiometabolic Syndrome.
Sverdlov AL; Figtree GA; Horowitz JD; Ngo DT
Mediators Inflamm; 2016; 2016():8254590. PubMed ID: 27563174
[No Abstract] [Full Text] [Related]
52. Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk.
Goldfine AB; Shoelson SE
J Clin Invest; 2017 Jan; 127(1):83-93. PubMed ID: 28045401
[TBL] [Abstract][Full Text] [Related]
53. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes.
Donath MY
Diabetologia; 2016 Apr; 59(4):679-82. PubMed ID: 26868493
[TBL] [Abstract][Full Text] [Related]
54. Influence of AMY1A copy number variations on obesity and other cardiometabolic risk factors: A review of the evidence.
Hariharan R; Mousa A; de Courten B
Obes Rev; 2021 Jun; 22(6):e13205. PubMed ID: 33432778
[TBL] [Abstract][Full Text] [Related]
55. C-reactive protein beyond biomarker of inflammation in metabolic syndrome.
Horiuchi M; Mogi M
Hypertension; 2011 Apr; 57(4):672-3. PubMed ID: 21357270
[No Abstract] [Full Text] [Related]
56. Meta-inflammation and cardiometabolic disease in obesity: Can heat therapy help?
Ely BR; Clayton ZS; McCurdy CE; Pfeiffer J; Minson CT
Temperature (Austin); 2018; 5(1):9-21. PubMed ID: 29687041
[TBL] [Abstract][Full Text] [Related]
57. Obesity and visceral fat: a growing inflammatory disease.
Hanauer SB
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):245. PubMed ID: 16265208
[No Abstract] [Full Text] [Related]
58. Human saliva as a tool to investigate intimate partner violence.
Punyadeera C
Brain Behav Immun; 2012 May; 26(4):541-2. PubMed ID: 22388099
[No Abstract] [Full Text] [Related]
59. Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes.
Shannon CE; Ní Chathail MB; Mullin SM; Meehan A; McGillicuddy FC; Roche HM
Rev Endocr Metab Disord; 2023 Oct; 24(5):921-936. PubMed ID: 37402955
[TBL] [Abstract][Full Text] [Related]
60. Obesity-related immune responses and their impact on surgical outcomes.
Quante M; Dietrich A; ElKhal A; Tullius SG
Int J Obes (Lond); 2015 Jun; 39(6):877-83. PubMed ID: 25697667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
